2012 -- H 7537 | |
======= | |
LC01179 | |
======= | |
STATE OF RHODE ISLAND | |
| |
IN GENERAL ASSEMBLY | |
| |
JANUARY SESSION, A.D. 2012 | |
| |
____________ | |
| |
A N A C T | |
RELATING TO FOOD AND DRUGS - UNIFORM CONTROLLED SUBSTANCES ACT | |
|
      |
|
      |
     Introduced By: Representatives McNamara, and Bennett | |
     Date Introduced: February 15, 2012 | |
     Referred To: House Health, Education & Welfare | |
It is enacted by the General Assembly as follows: | |
1-1 |
     SECTION 1. Section 21-28-3.18 of the General Laws in Chapter 21-28 entitled "Uniform |
1-2 |
Controlled Substances Act" is hereby amended to read as follows: |
1-3 |
     21-28-3.18. Prescriptions. -- (a) An apothecary in good faith may sell and dispense |
1-4 |
controlled substances in schedule II, III, IV and V to any person upon a |
1-5 |
by a practitioner licensed by law to prescribe or administer those substances, dated and signed by |
1-6 |
the person prescribing on the day when issued and bearing the full name and address of the |
1-7 |
patient to whom, or of the owner of the animal for which the substance is dispensed and the full |
1-8 |
name, address and registration number under the federal law of the person prescribing, if he or |
1-9 |
she is required by that law to be registered. If the prescription is for an animal, it shall state the |
1-10 |
species of the animal for which the substance is prescribed. |
1-11 |
      (b) |
1-12 |
apothecary filling the prescription shall sign his or her full name and shall write the date of filling |
1-13 |
on the face of the prescription. |
1-14 |
      (c) The prescription shall be retained on file by the proprietor of the pharmacy in which |
1-15 |
it was filled for a period of two (2) years so as to be readily accessible for inspection by any |
1-16 |
public officer or employee engaged in the enforcement of this chapter. |
1-17 |
      (d) (1) |
1-18 |
shall be filed separately and shall not be refilled. |
1-19 |
      (2) The director of health may, after appropriate notice and hearing pursuant to section |
1-20 |
42-35-3, promulgate rules and regulations for the purpose of adopting a system for electronic data |
2-1 |
transmission of prescriptions for controlled substances in schedule II |
2-2 |
     (3) A practitioner may sign and transmit electronic prescriptions for controlled substances |
2-3 |
and a pharmacy may dispense an electronically transmitted prescription in accordance with the |
2-4 |
Code of Federal Regulations, Title 21 Part 1300 to end. |
2-5 |
      (e) A prescription for a schedule II narcotic substance to be compounded for the direct |
2-6 |
administration to a patient by parenteral, intravenous, intramuscular, subcutaneous, or intraspinal |
2-7 |
infusion may be transmitted by the practitioner or practitioner's agent to the pharmacy by |
2-8 |
facsimile. The facsimile will serve as the original prescription. |
2-9 |
      (f) A prescription written for a schedule II substance for a resident of a long term care |
2-10 |
facility may be transmitted by the practitioner or the practitioner's agent to the dispensing |
2-11 |
pharmacy by facsimile. The facsimile serves as the original prescription. |
2-12 |
      (g) A prescription for a schedule II narcotic substance for a patient residing in a hospice |
2-13 |
certified by Medicare under title XVIII of the Social Security Act, 42 U.S.C. section 1395 et seq., |
2-14 |
or licensed by the state, may be transmitted by the practitioner or practitioner's agent to the |
2-15 |
dispensing pharmacy by facsimile. The practitioner or the practitioner's agent will note on the |
2-16 |
prescription that the patient is a hospice patient. The facsimile serves as the original written |
2-17 |
prescription. |
2-18 |
      (h) An apothecary, in lieu of a written prescription, may sell and dispense controlled |
2-19 |
substances in schedules III, IV, and V to any person upon an oral prescription of a practitioner. In |
2-20 |
issuing an oral prescription the prescriber shall furnish the apothecary with the same information |
2-21 |
as is required by subsection (a) of this section |
2-22 |
|
2-23 |
apothecary who fills the prescription, shall immediately reduce the oral prescription to writing |
2-24 |
and shall inscribe the information on the written record of the prescription made. This record shall |
2-25 |
be filed and preserved by the proprietor of the pharmacy in which it is filled in accordance with |
2-26 |
the provisions of subsection (c) of this section. In no case may a prescription for a controlled |
2-27 |
substance listed in schedules III, IV, or V be filled or refilled more than six (6) months after the |
2-28 |
date on which the prescription was issued and no prescription shall be authorized to be refilled |
2-29 |
more than five (5) times. Each refilling shall be entered on the face or back of the prescription |
2-30 |
and note the date and amount of controlled substance dispensed, and the initials or identity of the |
2-31 |
dispensing apothecary. |
2-32 |
      (i) In the case of an emergency situation as defined in federal law, an apothecary may |
2-33 |
dispense a controlled substance listed in schedule II upon receiving an oral authorization of a |
2-34 |
prescribing practitioner provided that: |
3-1 |
      (1) The quantity prescribed and dispensed is limited to the amount adequate to treat the |
3-2 |
patient during the emergency period and dispensing beyond the emergency period must be |
3-3 |
pursuant to a written prescription signed by the prescribing practitioner. |
3-4 |
      (2) The prescription shall be immediately reduced to writing and shall contain all the |
3-5 |
information required in subsection (a) of this section. |
3-6 |
      (3) The prescription must be dispensed in good faith in the normal course of professional |
3-7 |
practice. |
3-8 |
      (4) Within seven (7) days after authorizing an emergency oral prescription, the |
3-9 |
prescribing practitioner shall cause a |
3-10 |
be delivered to the dispensing apothecary. The prescription shall have written on its face |
3-11 |
"Authorization for emergency dispensing" and the date of the oral order. The |
3-12 |
upon receipt by the apothecary shall be attached to the oral emergency prescription which had |
3-13 |
earlier been reduced to writing. |
3-14 |
      (j) (1) The partial filling of a prescription for a controlled substance listed in schedule II |
3-15 |
is permissible, if the apothecary is unable to supply the full quantity called for in a |
3-16 |
prescription or emergency oral prescription and he or she makes a notation of the quantity |
3-17 |
supplied on the face of the |
3-18 |
reduced to writing. The remaining portion of the prescription may be filled within seventy-two |
3-19 |
(72) hours of the first partial filling, however, if the remaining portion is not, or cannot be filled |
3-20 |
within seventy-two (72) hours, the apothecary shall notify the prescribing practitioner. No further |
3-21 |
quantity may be supplied beyond seventy-two (72) hours without a new prescription. |
3-22 |
      (2) (i) A prescription for a schedule II controlled substance |
3-23 |
term care facility (LTCF), or for a patient with a medical diagnosis documenting a terminal |
3-24 |
illness, may be filled in partial quantities to include individual dosage units. If there is a question |
3-25 |
whether a patient may be classified as having a terminal illness, the pharmacist must contact the |
3-26 |
practitioner prior to partially filling the prescription. Both the pharmacist and the prescribing |
3-27 |
practitioner have a corresponding responsibility to assure that the controlled substance is for a |
3-28 |
terminally ill patient. |
3-29 |
      (ii) The pharmacist must record on the prescription whether the patient is "terminally ill" |
3-30 |
or an "LTCF patient." A prescription that is partially filled, and does not contain the notation |
3-31 |
"terminally ill" or "LTCF patient", shall be deemed to have been filled in violation of this chapter. |
3-32 |
      (iii) For each partial filling, the dispensing pharmacist shall record on the back of the |
3-33 |
prescription (or on another appropriate record, uniformly maintained, and readily retrievable), |
3-34 |
the: |
4-1 |
      (A) Date of the partial filling; |
4-2 |
      (B) Quantity dispensed; |
4-3 |
      (C) Remaining quantity authorized to be dispensed; and |
4-4 |
      (D) Identification of the dispensing pharmacist. |
4-5 |
      (iv) The total quantity of schedule II controlled substances dispensed in all partial fillings |
4-6 |
must not exceed the total quantity prescribed. |
4-7 |
      (v) Schedule II prescriptions for patients in a LTCF, or patients with a medical diagnosis |
4-8 |
documenting a terminal illness, are valid for a period not to exceed sixty (60) days from the issue |
4-9 |
date, unless sooner terminated by the discontinuance of medication. |
4-10 |
      (k) Automated data processing systems. - As an alternative to the prescription record |
4-11 |
keeping provision of subsection (h) of this section, an automated data processing system may be |
4-12 |
employed for the record keeping system, if the following conditions have been met: |
4-13 |
      (1) The system shall have the capability of producing sight-readable documents of all |
4-14 |
original and refilled prescription information. The term "sight-readable" means that an authorized |
4-15 |
agent shall be able to examine the record and read the information. During the course of an on- |
4-16 |
site inspection, the record may be read from the CRT, microfiche, microfilm, printout, or other |
4-17 |
method acceptable to the director. In the case of administrative proceedings, records must be |
4-18 |
provided in a paper printout form. |
4-19 |
      (2) The information shall include, but not be limited to, the prescription requirements |
4-20 |
and records of dispensing as indicated in subsection (h) of this section. |
4-21 |
      (3) The individual pharmacist responsible for completeness and accuracy of the entries |
4-22 |
to the system must provide documentation of the fact that prescription information entered into |
4-23 |
the computer is correct. In documenting this information, the pharmacy shall have the option to |
4-24 |
either: |
4-25 |
      (i) Maintain a bound log book, or separate file, in which each individual pharmacist |
4-26 |
involved in the dispensing shall sign a statement each day, attesting to the fact that the |
4-27 |
prescription information entered into the computer that day has been reviewed and is correct as |
4-28 |
shown. The book or file must be maintained at the pharmacy employing that system for a period |
4-29 |
of at least two (2) years after the date of last dispensing; or |
4-30 |
      (ii) Provide a printout of each day's prescription information. That printout shall be |
4-31 |
verified, dated, and signed by the individual pharmacist verifying that the information indicated is |
4-32 |
correct. The printout must be maintained at least two (2) years from the date of last dispensing. |
4-33 |
      (4) An auxiliary record keeping system shall be established for the documentation of |
4-34 |
refills, if the automated data processing system is inoperative for any reason. The auxiliary |
5-1 |
system shall ensure that all refills are authorized by the original prescription, and that the |
5-2 |
maximum number of refills is not exceeded. When this automated data processing system is |
5-3 |
restored to operation, the information regarding prescriptions filled and refilled during the |
5-4 |
inoperative period, shall be entered into the automated data processing system within ninety-six |
5-5 |
(96) hours. |
5-6 |
      (5) Any pharmacy using an automated data processing system must comply with all |
5-7 |
applicable state and federal laws and regulations. |
5-8 |
      (6) A pharmacy shall make arrangements with the supplier of data processing services or |
5-9 |
materials to ensure that the pharmacy continues to have adequate and complete prescription and |
5-10 |
dispensing records if the relationship with the supplier terminates for any reason. A pharmacy |
5-11 |
shall ensure continuity in the maintenance of records. |
5-12 |
      (7) The automated data processing system shall contain adequate safeguards for security |
5-13 |
of the records, to maintain the confidentiality and accuracy of the prescription information. |
5-14 |
Safeguards against unauthorized changes in data after the information has been entered and |
5-15 |
verified by the registered pharmacist shall be provided by the system. |
5-16 |
      (l) Prescriptions for controlled substances as found in schedules II, will become void |
5-17 |
unless dispensed within ninety (90) days of the original date of the prescription, and in no event |
5-18 |
shall more than a thirty (30) day supply be dispensed at any one time. |
5-19 |
      (1) In prescribing controlled substances in schedule II, practitioners may write up to |
5-20 |
three (3) separate prescriptions, each for up to a one-month supply, each signed and dated on the |
5-21 |
date written. For those prescriptions for the second and/or third month, the practitioner must write |
5-22 |
the earliest date each of those subsequent prescription may be filled, with directions to the |
5-23 |
pharmacist to fill no earlier than the date specified on the face of the prescription. |
5-24 |
      (m) The prescriptions in schedules III, IV, and V will become void unless dispensed |
5-25 |
within one hundred eighty (180) days of the original date of the prescription. For purposes of this |
5-26 |
section, a "dosage unit" shall be defined as a single capsule, tablet or suppository, or not more |
5-27 |
than one five (5) ml. of an oral liquid. |
5-28 |
      (1) Prescriptions in Schedule III cannot be written for more than one hundred (100) |
5-29 |
dosage units and not more than one hundred (100) dosage units may be dispensed at one time. |
5-30 |
      (2) Prescriptions in Schedule IV and V may be written for up to a ninety (90) day supply |
5-31 |
based on directions. No more than three hundred and sixty (360) dosage units may be dispensed |
5-32 |
at one time. |
6-33 |
     SECTION 2. This act shall take effect upon passage. |
      | |
======= | |
LC01179 | |
======= | |
EXPLANATION | |
BY THE LEGISLATIVE COUNCIL | |
OF | |
A N A C T | |
RELATING TO FOOD AND DRUGS - UNIFORM CONTROLLED SUBSTANCES ACT | |
*** | |
7-1 |
     This act would authorize the director of health, after appropriate notice and hearing, to |
7-2 |
promulgate rules and regulations for the purpose of adopting a system for electronic data |
7-3 |
transmission of prescriptions for controlled substances in schedule II, III, IV and V. |
7-4 |
     This act would take effect upon passage. |
      | |
======= | |
LC01179 | |
======= |